GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » LT-Debt-to-Total-Asset

Avid Bioservices (STU:TEHN) LT-Debt-to-Total-Asset : 0.12 (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Avid Bioservices LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Avid Bioservices's long-term debt to total assests ratio for the quarter that ended in Jan. 2024 was 0.12.

Avid Bioservices's long-term debt to total assets ratio declined from Jan. 2023 (0.40) to Jan. 2024 (0.12). It may suggest that Avid Bioservices is progressively becoming less dependent on debt to grow their business.


Avid Bioservices LT-Debt-to-Total-Asset Historical Data

The historical data trend for Avid Bioservices's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices LT-Debt-to-Total-Asset Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.20 0.44 0.42 0.42

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.42 0.42 0.43 0.12

Avid Bioservices LT-Debt-to-Total-Asset Calculation

Avid Bioservices's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Apr. 2023 is calculated as

LT Debt to Total Assets (A: Apr. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Apr. 2023 )/Total Assets (A: Apr. 2023 )
=171.342/411.361
=0.42

Avid Bioservices's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (Q: Jan. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Jan. 2024 )/Total Assets (Q: Jan. 2024 )
=47.892/417.898
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices  (STU:TEHN) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Avid Bioservices LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (STU:TEHN) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (STU:TEHN) Headlines

No Headlines